Multiple myeloma and malignant plasma cell neoplasms Clinical Trials

27 clinical trials for Multiple myeloma and malignant plasma cell neoplasms across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of training offers within the framework of the Center for Competence Development in Cancer Self-Help (ZfK KSH) — RECRUITING
• 68Ga-BCMA PET/CT in Multiple Myeloma — RECRUITING · PHASE2
• Prognostic and predictive cytogenetic variants in hematological neoplasia — RECRUITING
• Investigations into the influence of fludarabine exposure on the outcome of patients after CAR-T cell therapy — RECRUITING
• Prospective Examination on Neurocognitive Outcomes Following Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy — RECRUITING
• Multimodal Early Detection of CAR T-Cell-Associated Neurotoxicity — RECRUITING
• A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma — RECRUITING · PHASE1
• Screening of palliative care needs in patients with incurable hematological malignancies (PallHäm_101) — RECRUITING
• Analysis of organ function and comrbidity parameters, as well as established multiple myelom prognosis factors as structured, sysematic aquisition of age-associated concomitant factors and their prognostic relevance for evidence based assertions concerning therapy tolerance and survival in myelom patients. — RECRUITING
• Non interventionel prospective study to develop a prognostic scoring system for outcome of autologous transplantation in multiple myeloma (MM). — RECRUITING
• A phase II and phase III trial comparing treatment escalation and de-escalation strategies in newly diagnosed patients with multiple myeloma suitable for stem cell transplant — ACTIVE_NOT_RECRUITING · PHASE1_PHASE2
• Cross-Sectoral Care of Patients with Hematologic Diseases After Innovative Cell Therapy — OTHER
• Multiple Myeloma Extramedulary Disease Samples FFPE — NOT_YET_RECRUITING
• Multiple Myeloma t(4 ;14) FFPE Samples — NOT_YET_RECRUITING
• Clinical Evaluation of a Photon Counter Computer tomograph (Photon-Counting CT) — OTHER
• Bone Marrow Transplant in Treating Patients With Hematologic Cancers — COMPLETED · PHASE2
• Training in the handling of complementary medicine within the scope of the cancer self-help — OTHER
• Influence of the implementation of an interdisciplinary tumorconference of integrative oncologie on the treatment of oncological patients — OTHER
• T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases — TERMINATED · PHASE2
• Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myeloma — NOT_YET_RECRUITING
• Symptom Experience of Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation Following High Dose Chemotherapy — OTHER
• Effects of inpatient rehabilitation on gait and daily activity level of children and adolescents after oncological disease — OTHER
• Association of multiple myeloma (MM) with different neoplasms (DN), including second primary malignancies (SPM): systematic analysis in consecutive patients — OTHER
• Measurement of renal function with new equation and clinical implications in multiple myeloma patients receiving lenalidomide — OTHER
• Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. — OTHER · PHASE3
• Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders — COMPLETED · PHASE2
• Quantification of metabolism (F-18-Deoxyglucose) and bone turnover (F-18-Fluoride) using positron emission tomography and computed tomography (PET/CT) in patients with multiple myeloma and osteoporosis (B9-SFB-TR79) — NOT_YET_RECRUITING

Refine this search